Biogen’s Zurzuvae approved as first postpartum depression drug in Europe
Millions of parents in Europe who suffer from postpartum depression will now have access to a pharmaceutical treatment, following the…
Women's Health
-
-
Health Canada approves AbbVie’s Elahere for ovarian cancer
Health Canada has approved AbbVie's antibody-drug conjugate (ADC), Elahere (mirvetuximab soravtansine for injection), to treat adults with certain types of…
-
MHRA approves GSK’s oral antibiotic for UTIs in females
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to GSK's oral antibiotic pill, Blujepa (gepotidacin), for…
-
Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China
Daiichi Sankyo and AstraZeneca have received approval from China’s National Medical Products Administration (NMPA) for Datroway (datopotamab deruxtecan) to treat…
-
Gates Foundation invests $2.5bn in women’s health-focused R&D
The Gates Foundation has announced an investment of $2.5bn through to 2030, dedicated to expediting research and development (R&D) with…
-
Novartis’ ribociclib approved in Canada for early breast cancer
Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase inhibitor for the…
-
Scynexis resumes dosing in Phase III MARIO study after lengthy delay
Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a 19-month…
-
Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying…
-
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
The European Commission (EC) has approved Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) for use as a single agent to…
-
Genmab’s Tivdak approved in Japan for advanced cervical cancer
Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat advanced…
